Gene Therapy Market

Gene Therapy Market Size, Share, Growth Analysis, By Gene Type (Antigen, Cytokine), By Therapy type (Gene silencing therapy, Cell replacement therapy), By Vector type, By Delivery Method, By Route of Administration, By Application, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35H2218 | Region: Global | Published Date: December, 2025
Pages: 194 |Tables: 208 |Figures: 80

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Gene Therapy Market size was valued at USD 9.00 Billion in 2024 and is poised to grow from USD 10.93 Billion in 2025 to USD 51.55 Billion by 2033, growing at a CAGR of 21.4% during the forecast period (2026–2033).

    Krystal Biotech (United States), CRISPR Therapeutics (Switzerland), Beam Therapeutics (United States), Intellia Therapeutics (United States), Korro Bio (United States), Neurogene (United States), Sangamo Therapeutics (United States), MeiraGTx (United States), Verve Therapeutics (United States), Prime Medicine (United States), Taysha Gene Therapies (United States), enGene (Canada), Voyager Therapeutics (United States), Poseida Therapeutics (United States), uniQure (Netherlands), Editas Medicine (United States), Benitec Biopharma (United States), Cellectis S.A. (France), Adverum Biotechnologies (United States), Generation Bio (United States)

    The key driver of the gene therapy market is the rising prevalence of genetic and chronic diseases, which boosts demand for innovative, targeted treatments that can provide long-term benefits and improve patient outcomes.

    A key market trend in the gene therapy market is the increasing development of personalized and advanced gene-editing technologies, such as CRISPR, which enable more precise, effective treatments and attract substantial investment and clinical research globally.

    North America accounted for the largest share in the gene therapy market, driven by strong biotechnology infrastructure, high research funding, early adoption of advanced therapies, supportive regulatory frameworks, and the presence of major pharmaceutical and biotech companies.

    Related Reports

    Cancer Gene Therapy Market
    Buy Now GET FREE SAMPLE
    Gene Editing Market
    Buy Now GET FREE SAMPLE
    Nucleic Acid Therapeutics Market
    Buy Now GET FREE SAMPLE
    Stem Cell Therapy Market
    Buy Now GET FREE SAMPLE
    Cancer Biological Therapy Market
    Buy Now GET FREE SAMPLE
    mRNA Therapeutics Market
    Buy Now GET FREE SAMPLE
    Gene Synthesis Market
    Buy Now GET FREE SAMPLE
    Gene Amplification Technologies Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Gene Therapy Market

    Report ID: SQMIG35H2218

    $5,300
    BUY NOW